Queensland Bauxite Ltd

ASX:QBL ISIN:AU000000QBL4

Queensland Bauxite Ltd ASX QBLQueensland Bauxite Limited (ASX:QBL) is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company's lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has agreed to acquire a 100% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries, and a 100% shareholding in Medcan Australia Pty Ltd, a company with an ODC cultivation and production License and a DA approved Cannabis production and manufacturing facility.

 
   
           

View in Other Languages

News

Queensland Bauxite Ltd (ASX:QBL) ASX Approval Letter and Terms of ASX Waivers

🕔1/14/2019 3:49:35 PM 5647

Queensland Bauxite Limited (ASX:QBL) is most pleased to announce that the Company has received the formal approval letter for its application for reinstatement to the official list of ASX Limited.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Quarterly Activities Report

🕔11/1/2018 8:11:07 AM 4746

Queensland Bauxite Ltd (ASX:QBL) provides the Company's Quarterly Activities Report.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Cover Note and Second Supplementary Prospectus

🕔11/1/2018 8:10:02 AM 4703

Queensland Bauxite Ltd (ASX:QBL) provides the Company's cover note and second supplementary prospectus.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Strategic Collaboration and Supply Agreement Signed with Canadian Licensed Producer

🕔10/24/2018 9:24:58 AM 5100

The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a Strategic Collaboration and Supply Agreement Signed with an established Canadian Licensed Producer of Medical Cannabis.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Annual Report to Shareholders

🕔10/23/2018 2:17:03 PM 5467

Queensland Bauxite Ltd (ASX:QBL) provides the Company's Annual Report to shareholders.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) JV with Leading Israeli Medicinal Cannabis Company Pharmocann

🕔10/19/2018 9:51:24 AM 6398

The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a memorandum of understanding with top Israeli medicinal cannabis company Pharmocann.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Cover Note and Supplementary Prospectus

🕔10/18/2018 9:47:17 AM 4938

This attached supplementary prospectus of Queensland Bauxite Ltd (ASX:QBL) has included some updated information on the original prospectus that was lodged with the ASIC on 27 September 2018.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Office of Drug Control Manufacture Licence Secured

🕔10/10/2018 8:35:54 AM 5942

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that its soon to be wholly owned subsidiary, Medcan Australia, has secured a Medical Cannabis Manufacture Licence under the ODC.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Recompliance Prospectus

🕔9/28/2018 9:24:06 AM 6836

Queensland Bauxite Ltd (ASX:QBL) Prospectus has been prepared for an offer of up to 170,000,000 new Shares at an issue price of $0.035 per Share to raise up to $5,950,000, with a minimum subscription of $1,995,000 together with one (1) free attaching Option for every two (2) Shares subscribed for and issued.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Letter from the Chairperson

🕔8/22/2018 9:32:46 AM 5911

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to present a set of proposed resolutions and explanatory statements, which will see the merger of Medical Cannabis Limited into the Company and the acquisition of MedCan Australia, enabling the Company to have all the licences and facilities currently needed, to progress the Cannabis business and humanitarian goals of the company.

Read Full Article
###

202,699 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 180) (Last 30 Days: 741) (Since Published: 59054) 

Company Data

    Headquarters
  • 24 Birriga Rd
    Bellevue Hill
    NSW 2023
    Australia
  • Telephone
  • +61-2-9291-9000 
  • Fax
  • +61-2-9291-9099 
  • Principal Sector
  • Mining 
  • Principal Industry
  • Mining & Metals 
  • Homepage
  • www.queenslandbauxite.com.au
  • E:
  • info@queenslandbauxite.com.au

Company Reports

Quarterly Report

Download Presentation

Social Media